#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary hypophosphataemic rickets Anti-HLA antibody test positive Alagille syndrome Glycogen storage disease type I Craniopharyngioma Mantle cell lymphoma stage II Macular telangiectasia KBG syndrome Thrombocytosis Juvenile psoriatic arthritis Kidney transplant rejection Extra-osseous Ewing's sarcoma recurrent Acute graft versus host disease in skin Deafness neurosensory Neonatal alloimmune thrombocytopenia More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma recurrent – Trials in Disease Hepatoblastoma – Treatment Glycogen storage disease type II – Diagnostics Cytokine release syndrome – Life with Disease Andersen-Tawil syndrome – Treatment Primary immunodeficiency syndrome – Basic Information Idiopathic inflammatory myopathy – Diagnostics Pulmonary fibrosis – Life with Disease Anaplastic thyroid cancer – Treatment Thrombotic thrombocytopenic purpura – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    OMECAMTIV MECARBIL Lazertinib Sodium Hydrogen Carbonate Plasma Mitoxantrone Zopiclone Potassium Oxybate Indometacin Ph. Eur. Tas3351 Tumor Necrosis Factor-Alpha GOCATAMIG DESMOPRESSIN ACETATE Ecoo15 Iohexol Meglumine Gadoterate Gen1055 Revumenib Ganaxolone Specific Nucleic Acid Sna-Ebv Mk-1084 More therapies…

    Learn about Your Condition

    Urethral stenosis Catatonia Respiratory failure Microscopic polyangiitis Rectal cancer Mental disorder Primary hyperthyroidism Small intestine carcinoma Rectal adenocarcinoma Cutibacterium acnes infection Plasma cell myeloma refractory Still's disease Febrile neutropenia Benign prostatic hyperplasia Abdominal wall pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of mezigdomide and elranatamab combination treatment for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Mezigdomide
    • Dexamethasone
    • Elranatamab
    Germany Greece Norway Spain

  • Study of N-acetylcysteine and prednisolone combination versus extended prednisolone treatment in patients with severe alcoholic hepatitis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hepatitis alcoholic
    Investigated Drugs:
    • Acetylcysteine
    • Prednisolone Metasulfobenzoate Sodium
    • Prednisolone
    France

  • Study of NGM120 in patients with colorectal cancer and cancer cachexia: Evaluating effects on body weight

    Recruiting

    2 1
    Investigated Drugs:
    • HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST GDNF FAMILY RECEPTOR ALPHA-LIKE
    Bulgaria Czechia Hungary Poland Slovakia

  • Study of nirsevimab and RSV vaccine (Abrysvo) for prevention of respiratory syncytial virus infection in infants during their first year of life

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bronchiolitis
    • Respiratory syncytial virus infection
    France

  • Study of BNT314 and BNT327 with chemotherapy for patients with metastatic colorectal cancer

    Recruiting

    1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    • Colorectal cancer
    Investigated Drugs:
    • Bnt314
    • BNT327
    Germany Spain

  • Study of Axatilimab compared to standard therapy in children with chronic graft-versus-host disease who have previously received at least 2 treatments

    Recruiting

    2 1 1
    Investigated Drugs:
    • Axatilimab
    Belgium Germany Italy Spain
Previous Page
1 … 118 119 120 121 122 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!